Pittsburgh, Pennsylvania, United States , May 10, 2022 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. is announcing the Radiation Cystitis Patient Registry, an on-line patient registry program for ...

Hemorrhagic cystitis (HC) is a frequent and sometimes life-threatening complication after hematopoietic SCT (HSCT). Many therapeutic approaches have been performed to control HC, but their effect is ...

April 28, 2005 — Hyperbaric oxygen (HBO 2) therapy given within six months of hematuria onset is effective for radiation-induced hemorrhagic cystitis, according to the results of a retrospective study ...

Hemorrhagic cystitis (HC) is a well-recognized complication of hematopoietic stem cell transplantation (HSCT) in children and adolescents. The etiology is often multi-factorial and includes ...

PITTSBURGH--(BUSINESS WIRE)--Lipella Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on improving cancer survivorship, today announced it has begun recruiting patients in the ...

PITTSBURGH, April 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: “LIPO”) (“Lipella,” “our,” “us” or the “Company”), a clinical ...

Posoleucel is being investigated for the treatment and prevention of serious diseases caused by 6 viral pathogens. The Food and Drug Administration (FDA) has granted Orphan Drug designation to ...

Please provide your email address to receive an email when new articles are posted on . BK virus-specific cytotoxic T lymphocytes from healthy donors appeared safe and effective for patients with BK ...

Medical researchers have turned the tables on Schistosoma haematobium, a parasitic worm that freeloads in humans, by using a protein derived from the parasite as a therapeutic molecule to reduce ...

Background. BK virus-associated hemorrhagic cystitis (BKV-HC) is a severe complication after allogeneic hematopoietic stem cell transplantation (HSCT), but antiviral treatment for this condition has ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug ...